Feed / Theme
Confirmed

Clinical Stage Biotech

3 names are moving together; 33% are participating in the current session.

Co-movement

Observed intraday paths are not available for this group yet.

Members

TICKERCompanySectorTodayObserved activity
ABVXAbivax SAHealthcare-0.9%Group member
USLMUnited States Lime & Minerals,Basic Materials+0.6%Group member
SEBSeaboard CorporationIndustrials-1.3%Most structurally connected

Why we believe this

Cohort

3 names

Participation

33% this session

Observed history

1 daily builds

Filing coverage

2/3 members

demand / volume affecting revenue

Environmental credit sales were relatively flat due to higher sales prices, which increased sales $24 million, partially offset by lower volumes sold that decreased sales $19 million.

SEB 10-Q

demand / volume

The cost and supply of feed components and other raw materials are determined by constantly changing market forces of supply and demand, which are driven by matters over which these segments have no control, including inflation, weather, current and projected worldwide grain stocks and prices, grain export prices, subsidies and tariffs, and governmental agricultural policies.

SEB 10-K

legal / regulatory

The aggregate minimum principal payments required on long-term debt as of December 31, 2025, were as follows: $ 11 million in 2026, $ 41 million in 2027, $ 11 million in 2028, $ 11 million in 2029, $ 11 million in 2030 and $ 906 million thereafter. ​ Note 8 − Commitments and Contingencies Legal Proceedings Seaboard is subject to various legal proceedings and claims that arise in the ordinary course of business and otherwise, including those matters described below.

SEB 10-K

Cross-asset confirmation is still fragile, so spillover can stall before it becomes durable.

Connected, outside the group

No high-confidence filing-linked non-members are available for this group yet.

History

Historical cohort observations are not available yet.